Physician profile
Rameez H Phulpoto
NPI 1134560071
$226.21
in general payments reported to CMS, 2019-2025
7 companies · $32.86 in 2025
The $32.86 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.45 · 2020: $28.70 · 2021: $62.17 · 2022: $65.03 · 2025: $32.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $59.35 | 2020-2021 | |
| Shionogi INC | $45.09 | 2022 | |
| Abbvie INC. | $36.64 | 2021-2022 | |
| Gilead Sciences, INC. | $32.86 | 2025 | |
| Genentech, INC. | $19.08 | 2019 | |
| Insmed, INC. | $18.37 | 2019 | |
| Merck Sharp & Dohme LLC | $14.82 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rameez Phulpoto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.